Editas Medicine, Inc.

EDITNasdaqCIK 1650664HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 192 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Editas Medicine, Inc., Reports and events
Filed	Form	What it is	Accession number
2021-01-1916:37 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001104659-21-005360
2021-01-1116:06 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0001104659-21-002967
2020-12-1816:22 ET	8-K	5.02 Departure or appointment of officers or directors	0001558370-20-014467
2020-11-0608:07 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001558370-20-013022
2020-11-0516:17 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-20-012865
2020-08-0708:07 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001558370-20-009821
2020-08-0616:10 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-20-009648
2020-06-2509:16 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001104659-20-076658
2020-06-1516:06 ET	8-K	5.07 Shareholder vote results	0001558370-20-007536
2020-05-1516:04 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001558370-20-006724
2020-05-0808:32 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001558370-20-005883
2020-05-0707:35 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-20-005548
2020-05-0609:15 ET	8-K	5.02 Departure or appointment of officers or directors	0001558370-20-005306
2020-04-2816:01 ET	DEF 14A	Proxy statementPeriod 2020-06-10	0001047469-20-002641
2020-02-2616:26 ET	10-K	Annual reportPeriod 2019-12-31	0001558370-20-001476
2020-02-2616:12 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-20-001469
2020-01-1016:01 ET	8-K	5.02 Departure or appointment of officers or directors	0001558370-20-000118
2019-11-1216:04 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001558370-19-010798
2019-11-1207:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-19-010674
2019-09-3016:11 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001558370-19-008737
2019-08-0716:13 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001558370-19-007470
2019-08-0616:32 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-19-007255
2019-06-1416:03 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results	0001558370-19-005722
2019-05-0816:03 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001558370-19-004444
2019-05-0716:10 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-19-004256
2019-04-2616:06 ET	DEF 14A	Proxy statementPeriod 2019-06-12	0001047469-19-002633
2019-03-0118:03 ET	10-K	Annual reportPeriod 2018-12-31	0001558370-19-001364
2019-02-2816:11 ET	8-K	1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-19-001317
2019-02-0716:01 ET	8-K	5.02 Departure or appointment of officers or directors	0001558370-19-000455
2019-01-2209:07 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001558370-19-000186
2018-12-2109:15 ET	8-K	5.02 Departure or appointment of officers or directors	0001558370-18-009781
2018-12-1009:10 ET	8-K	5.02 Departure or appointment of officers or directors	0001558370-18-009647
2018-11-0808:46 ET	10-Q	Quarterly reportPeriod 2018-09-30	0001558370-18-008907
2018-11-0716:12 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-18-008795
2018-10-2316:01 ET	10-Q/A	Quarterly report, amendedPeriod 2018-06-30	0001558370-18-007793
2018-08-0716:02 ET	10-Q	Quarterly reportPeriod 2018-06-30	0001558370-18-006577
2018-08-0616:10 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001558370-18-006448
2018-06-1916:02 ET	8-K	5.07 Shareholder vote results	0001558370-18-005339
2018-06-0816:18 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-18-039187
2018-06-0816:01 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation	0001558370-18-005194
2018-05-0416:03 ET	10-Q	Quarterly reportPeriod 2018-03-31	0001558370-18-004024
2018-05-0316:12 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-18-003889
2018-04-2708:30 ET	DEF 14A	Proxy statementPeriod 2018-06-15	0001047469-18-003271
2018-03-2816:05 ET	8-K	5.02 Departure or appointment of officers or directors	0001558370-18-002469
2018-03-0816:36 ET	10-K	Annual reportPeriod 2017-12-31	0001558370-18-001721
2018-03-0616:12 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001558370-18-001558
2018-02-1616:03 ET	8-K	5.02 Departure or appointment of officers or directors	0001558370-18-000748
2018-01-2216:46 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-18-003319
2018-01-1216:07 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-18-002064
2018-01-0416:21 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-18-000786

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:42 ET. Listed shows no prices and gives no investment advice.